Autologous G-CSF-mobilized peripheral blood CD34+ cell therapy for diabetic patients with chronic nonhealing ulcer

Cell Transplantation

Volumn 23, Issue 2, 2014, Pages 167-179

  Tanaka, Rica ^a,b   Masuda, Haruchika ^b   Kato, Shunichi ^b   Imagawa, Kotaro ^b   Kanabuchi, Kazuo ^b   Nakashioya, Chie ^b   Yoshiba, Fumiaki ^b   Fukui, Tsuyoshi ^b   Ito, Rie ^b   Kobori, Michiru ^b   Wada, Mika ^b   Asahara, Takayuki ^b   Miyasaka, Muneo ^b  

^a JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Autologous cell therapy; Endothelial progenitor cells (EPC); Nonhealing diabetic wound; Vasculogenesis; Wound healing

Indexed keywords

GRANULOCYTE COLONY STIMULATING FACTOR;

ADULT; AGED; AMPUTATION; ARTICLE; CD34 T LYMPHOCYTE; CELL THERAPY; CLINICAL ARTICLE; DIABETES MELLITUS; DIABETIC PATIENT; ENDOTHELIAL PROGENITOR CELL; FEMALE; HUMAN; HUMAN TISSUE; MALE; MIDDLE AGED; PRIORITY JOURNAL; RECURRENT DISEASE; STEM CELL TRANSPLANTATION; T LYMPHOCYTE; ULCER; WOUND CLOSURE; WOUND HEALING;

ADULT; AGED; ANTIGENS, CD34; CELL- AND TISSUE-BASED THERAPY; FEMALE; FOOT ULCER; GRANULOCYTE COLONY-STIMULATING FACTOR; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; STEM CELLS; WOUND HEALING;

EID: 84893225269     PISSN: 09636897     EISSN: None     Source Type: Journal    
DOI: 10.3727/096368912X658007     Document Type: Article

References (37)

1. Asahara, T.; Masuda, H.; Takahashi, T.; Kalka, C.; Pastore, C.; Silver, M.; Kearne, M.; Magner, M.; Isner, J. M. Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ. Res. 85(3):221-228; 1999.
2. Asahara, T.; Murohara, T.; Sullivan, A.; Silver, M.; van der Zee, R.; Li, T.; Witzenbichler, B.; Schatteman, G.; Isner, J. M. Isolation of putative progenitor endothelial cells for angiogenesis. Science 275(5302):964-967; 1997.
3. Bauer, S. M.; Goldstein, L. J.; Bauer, R. J.; Chen, H.; Putt, M.; Velazquez, O. C. The bone marrow-derived endothelial progenitor cell response is impaired in delayed wound healing from ischemia. J. Vasc. Surg. 43(1):134-141; 2006.
4. Brooks, B.; Dean, R.; Patel, S.; Wu, B.; Molyneaux, L.; Yue, D. K. TBI or not TBI: That is the question. Is it better to measure toe pressure than ankle pressure in diabetic patients? Diabet. Med. 18(7):528-532; 2001.
5. Brunner, S.; Schernthaner, G. H.; Satler, M.; Elhenicky, M.; Hoellerl, F.; Schmid-Kubista, K. E.; Zeiler, F.; Binder, S.; Schernthaner, G. Correlation of different circulating endothelial progenitor cells to stages of diabetic retinopathy: First in vivo data. Invest. Ophthalmol. Vis. Sci. 50(1):392-398; 2009.
6. Capla, J. M.; Grogan, R. H.; Callaghan, M. J.; Galiano, R. D.; Tepper, O. M.; Ceradini, D. J.; Gurtner, G. C. Diabetes impairs endothelial progenitor cell-mediated blood vessel formation in response to hypoxia. Plast. Reconstr. Surg. 119(1):59-70; 2007.
7. Ceradini, D. J.; Kulkarni, A. R.; Callaghan, M. J.; Tepper, O. M.; Bastidas, N.; Kleinman, M. E.; Capla, J. M.; Galiano, R. D.; Levine, J. P.; Gurtner, G. C. Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1. Nat. Med. 10(8):858-864; 2004.
8. Fang, Y.; Shen, J.; Yao, M.; Beagley, K. W.; Hambly, B. D.; Bao, S. Granulocyte-macrophage colony-stimulating factor enhances wound healing in diabetes via upregulation of proinflammatory cytokines. Br. J. Dermatol. 162(3):478-486; 2010.
9. Friedrich, E. B.; Walenta, K.; Scharlau, J.; Nickenig, G.; Werner, N. CD34-/CD133+/VEGFR-2+ endothelial progenitor cell subpopulation with potent vasoregenerative capacities. Circ. Res. 98(3):e20-e25; 2006.
10. Griffin, K. J.; Rashid, T. S.; Bailey, M. A.; Bird, S. A.; Bridge, K.; Scott, J. D. Toe Amputation: A predictor of future limb loss? J. Diabetes Complications 26(3):251-254; 2012.
11. Hendrikx, M.; Hensen, K.; Clijsters, C.; Jongen, H.; Koninckx, R.; Bijnens, E.; Ingels, M.; Jacobs, A.; Geukens, R.; Dendale, P.; Vijgen, J.; Dilling, D.; Steels, P.; Mees, U.; Rummens, J. L. Recovery of regional but not global contractile function by the direct intramyocardial autologous bone marrow transplantation: Results from a randomized controlled clinical trial. Circulation 114(1 Suppl):I101-I107; 2006.
12. Holstein, P.; Lassen, N. A. Healing of ulcers on the feet correlated with distal blood pressure measurements in occlusive arterial disease. Acta Orthop. Scand. 51(6):995-1006; 1980.
13. Huang, P.; Li, S.; Han, M.; Xiao, Z.; Yang, R. Han, Z. C. Autologous transplantation of granulocyte colony-stimulating factor-mobilized peripheral blood mononuclear cells improves critical limb ischemia in diabetes. Diabetes Care 28(9):2155-2160; 2005.
14. Ii, M.; Nishimura, H.; Iwakura, A.; Wecker, A.; Eaton, E.; Asahara, T.; Losordo, D. W. Endothelial progenitor cells are rapidly recruited to myocardium and mediate protective effect of ischemic preconditioning via "imported" nitric oxide synthase activity. Circulation 111(9):1114-1120; 2005.
15. Izumi, Y.; Satterfield, K.; Lee, S.; Harkless, L. B.; Lavery, L. A. Mortality of first-time amputees in diabetics: A 10-year observation. Diabetes Res. Clin. Pract. 83(1):126-131; 2009.
16. Kawamoto, A.; Katayama, M.; Handa, N.; Kinoshita, M.; Takano, H.; Horii, M.; Sadamoto, K.; Yokoyama, A.; Yamanaka, T.; Onodera, R.; Kuroda, A.; Baba, R.; Kaneko, Y.; Tsukie, T.; Kurimoto, Y.; Okada, Y.; Kihara, Y.; Morioka, S.; Fukushima, M.; Asahara, T. Intramuscular transplantation of G-CSF-mobilized CD34(+) cells in patients with critical limb ischemia: A phase I/IIa, multicenter, single-blinded, dose-escalation clinical trial. Stem Cells 27(11):2857-2864; 2009.
17. Kwon, S. M.; Lee, Y. K.; Yokoyama, A.; Jung, S. Y.; Masuda, H.; Kawamoto, A.; Lee, Y. M.; Asahara, T. Differential activity of bone marrow hematopoietic stem cell subpopulations for EPC development and ischemic neovascularization. J. Mol. Cell. Cardiol. 51(3):308-317; 2011.
18. Lawall, H.; Bramlage, P.; Amann, B. Stem cell and progenitor cell therapy in peripheral artery disease. A critical appraisal. Thromb. Haemost. 103(4):696-709; 2010.
19. Lin, C. D.; Allori, A. C.; Macklin, J. E.; Sailon, A. M.; Tanaka, R.; Levine, J. P.; Saadeh, P. B.; Warren, S. M. Topical lineage-negative progenitor-cell therapy for diabetic wounds. Plast. Reconstr. Surg. 122(5):1341-1351; 2008.
20. Margolis, D. J.; Kantor, J.; Berlin, J. A. Healing of diabetic neuropathic foot ulcers receiving standard treatment. A metaanalysis. Diabetes Care 22(5):692-695; 1999.
21. Masuda, H.; Alev, C.; Akimaru, H.; Ito, R.; Shizuno, T.; Kobori, M.; Horii, M.; Ishihara, T.; Isobe, K.; Isozaki, M.; Itoh, J.; Itoh, Y.; Okada, Y.; McIntyre, B. A.; Kato, S.; Asahara, T. Methodological development of a clonogenic assay to determine endothelial progenitor cell potential. Circ. Res. 109(1):20-37; 2011.
22. Masuda, H.; Kalka, C.; Takahashi, T.; Yoshida, M.; Wada, M.; Kobori, M.; Itoh, R.; Iwaguro, H.; Eguchi, M.; Iwami, Y.; Tanaka, R.; Nakagawa, Y.; Sugimoto, A.; Ninomiya, S.; Hayashi, S.; Kato, S.; Asahara, T. Estrogen-mediated endothelial progenitor cell biology and kinetics for physiological postnatal vasculogenesis. Circ. Res. 101(6):598-606; 2007.
23. Miyamoto, Y.; Suyama, T.; Yashita, T.; Akimaru, H.; Kurata, H. Bone marrow subpopulations contain distinct types of endothelial progenitor cells and angiogenic cytokine-producing cells. J. Mol. Cell. Cardiol. 43(5):627-635; 2007.
24. Onodera, R.; Teramukai, S.; Tanaka, S.; Kojima, S.; Horie, T.; Matoba, S.; Murohara, T.; Matsubara, H.; Fukushima, M. Bone marrow mononuclear cells versus G-CSF-mobilized peripheral blood mononuclear cells for treatment of lower limb ASO: Pooled analysis for long-term prognosis. Bone Marrow Transplant. 46(2):278-284; 2011.
25. Quigley, F. G.; Faris, I. B.; Duncan, H. J. A comparison of Doppler ankle pressures and skin perfusion pressure in subjects with and without diabetes. Clin. Physiol. 11(1):21-25; 1991.
26. Saar, W. E.; Lee, T. H.; Berlet, G. C. The economic burden of diabetic foot and ankle disorders. Foot Ankle Int. 26(1):27-31; 2005.
27. Sander, A. L.; Jakob, H.; Henrich, D.; Powerski, M.; Witt, H.; Dimmeler, S.; Barker, J.; Marzi, I.; Frank, J. Systemic transplantation of progenitor cells accelerates wound epithelialization and neovascularization in the hairless mouse ear wound model. J. Surg. Res. 165(1):165-170; 2011.
28. Sivan-Loukianova, E.; Awad, O. A.; Stepanovic, V.; Bickenbach, J.; Schatteman, G. C. CD34+ blood cells accelerate vascularization and healing of diabetic mouse skin wounds. J. Vasc. Res. 40(4):368-377; 2003.
29. Snyder, R. J.; Hanft, J. R. Diabetic foot ulcers-Effects on QOL, costs, and mortality and the role of standard wound care and advanced-care therapies. Ostomy Wound Manage. 55(11):28-38; 2009.
30. Suh, W.; Kim, K. L.; Kim, J. M.; Shin, I. S.; Lee, Y. S.; Lee, J. Y.; Jang, H. S.; Lee, J. S.; Byun, J.; Choi, J. H.; Jeon, E. S.; Kim, D. K. Transplantation of endothelial progenitor cells accelerates dermal wound healing with increased recruitment of monocytes/macrophages and neovascularization. Stem Cells 23(10):1571-1578; 2005.
31. Takahashi, T.; Kalka, C.; Masuda, H.; Chen, D.; Silver, M.; Kearney, M.; Magner, M.; Isner, J. M.; Asahara, T. Ischemia-and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization. Nat. Med. 5(4):434-438; 1999.
32. Tanaka, R.; Wada, M.; Kwon, S. M.; Masuda, H.; Carr, J.; Ito, R.; Miyasaka, M.; Warren, S. M.; Asahara, T.; Tepper, O. M. The effects of flap ischemia on normal and diabetic progenitor cell function. Plast. Reconstr. Surg. 121(6):1929-1942; 2008.
33. Tei, K.; Matsumoto, T.; Mifune, Y.; Ishida, K.; Sasaki, K.; Shoji, T.; Kubo, S.; Kawamoto, A.; Asahara, T.; Kurosaka, M.; Kuroda, R. Administrations of peripheral blood CD34-positive cells contribute to medial collateral ligament healing via vasculogenesis. Stem Cells 26(3):819-830; 2008.
34. Tepper, O. M.; Galiano, R. D.; Capla, J. M.; Kalka, C.; Gagne, P. J.; Jacobowitz, G. R.; Levine, J. P.; Gurtner, G. C. Human endothelial progenitor cells from type II diabetics exhibit impaired proliferation, adhesion, and incorporation into vascular structures. Circulation 106(22):2781-2786; 2002.
35. Tsai, F. W.; Tulsyan, N.; Jones, D. N.; Abdel-Al, N.; Castronuovo, J. J., Jr.; Carter, S. A. Skin perfusion pressure of the foot is a good substitute for toe pressure in the assessment of limb ischemia. J. Vasc. Surg. 32(1):32-36; 2000.
36. Wang, Y.; Tagil, K.; Ripa, R. S.; Nilsson, J. C.; Carstensen, S.; Jorgensen, E.; Sondergaard, L.; Hesse, B.; Johnsen, H. E.; Kastrup, J. Effect of mobilization of bone marrow stem cells by granulocyte colony stimulating factor on clinical symptoms, left ventricular perfusion and function in patients with severe chronic ischemic heart disease. Int. J. Cardiol. 100(3):477-483; 2005.
37. Zimny, S.; Schatz, H.; Pfohl, M. Determinants and estimation of healing times in diabetic foot ulcers. J. Diabetes Complications 16(5):327-332; 2002.